Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6385290 | 0.98 | CYP19A1 (0.32) | CYP19A1 | |
| SCHEMBL6385818 | 0.80 | NPC1 (0.30) | CYP19A1NPC1ALDH1A1PLA2G1BNFKB1 | |
| Hydrochloric Acid SCHEMBL6386343 | 0.79 | — | — | |
| SCHEMBL7542664 | 0.74 | GPR3 (0.33) | — | |
| SCHEMBL5820549 | 0.69 | — | — | |
| SCHEMBL8397304 | 0.66 | NPC1 (0.31) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL6693816 | 0.64 | NPC1 (0.33) | CYP19A1NPC1ALDH1A1PLA2G1BNFKB1 | |
| SCHEMBL1452784 | 0.64 | NPC1 (0.33) | NPC1RAB9A | |
| SCHEMBL26004981 | 0.63 | ALDH1A1 (0.57) | CYP19A1NPC1ALDH1A1PLA2G1BNFKB1 | |
| SCHEMBL5546203 | 0.63 | ALDH1A1 (0.57) | CYP19A1NPC1ALDH1A1PLA2G1BNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006137818-A1 | CATALYST COMPONENTS AND THEIR USE IN THE POLYMERIZATION OF OLEFINS | FINA TECHNOLOGY, INC. (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20050148460-A1 | Catalyst components and their use in the polymerization of olefins | FINA TECHNOLOGY, INC. | 2005-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148460-A1 | Catalyst components and their use in the polymerization of olefins | NPY5R, SSTR5, FGR | CYP19A1 165/4885NPC1 3753/4885ALDH1A1 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.